Search
for
Sort by
Research 931–960 of 1000+
- A Pilot Study of a Grape Seed Procyanidin Extract for Lung Cancer Chemoprevention
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Cancer risk by the subtype of alopecia
- Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
- A Phase II Study of Vaginal Testosterone Cream (TEST) vs. Estring for Vaginal Dryness or Decreased Libido in Women with Early Stage Breast Cancer (BC) Treated with Aromatase Inhibitors (AIs).
- Understanding the role of sex hormones in cancer for the transgender community
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer
- Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity
- Small cell lung cancer: Results of a phase II study of 1,2,4 triglycidylurazol
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Targeting the (Un)differentiated State of Cancer
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Cancer Chemotherapy: an Introduction
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy
- Zinc deficiency is associated with gynecologic cancer recurrence
- Can social media encourage young Polish adults to visit a dermatologist? An original study
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Cancer Treatments and Alopecia: A Systematic Review
- Skin in the Game: Stem Cells in Repair, Cancer, and Homeostasis
- Dermatologic Adverse Events from Cancer Treatments
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer